BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17668885)

  • 21. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.
    Byfield MP; Murray JT; Backer JM
    J Biol Chem; 2005 Sep; 280(38):33076-82. PubMed ID: 16049009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
    Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity.
    Um SH; Frigerio F; Watanabe M; Picard F; Joaquin M; Sticker M; Fumagalli S; Allegrini PR; Kozma SC; Auwerx J; Thomas G
    Nature; 2004 Sep; 431(7005):200-5. PubMed ID: 15306821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin.
    Andreelli F; Foretz M; Knauf C; Cani PD; Perrin C; Iglesias MA; Pillot B; Bado A; Tronche F; Mithieux G; Vaulont S; Burcelin R; Viollet B
    Endocrinology; 2006 May; 147(5):2432-41. PubMed ID: 16455782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of the activities of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2-deoxyglucose.
    Jiang W; Zhu Z; Thompson HJ
    Mol Carcinog; 2008 Aug; 47(8):616-28. PubMed ID: 18247380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice.
    Quan HY; Yuan HD; Jung MS; Ko SK; Park YG; Chung SH
    Int J Mol Med; 2012 Jan; 29(1):73-80. PubMed ID: 21971952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice.
    Zang M; Xu S; Maitland-Toolan KA; Zuccollo A; Hou X; Jiang B; Wierzbicki M; Verbeuren TJ; Cohen RA
    Diabetes; 2006 Aug; 55(8):2180-91. PubMed ID: 16873680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Shenzhu Tiaopi granule on hepatic insulin resistance in diabetic Goto-Kakizakirats via liver kinase B1/adenosine 5'-monophosphate/mammalian target of rapamycin signaling pathway.
    Yin Y; Fang Z; Wu Y; You L
    J Tradit Chin Med; 2021 Feb; 41(1):107-116. PubMed ID: 33522203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation.
    Han CY; Ki SH; Kim YW; Noh K; Lee DY; Kang B; Ryu JH; Jeon R; Kim EH; Hwang SJ; Kim SG
    Antioxid Redox Signal; 2011 Jan; 14(2):187-202. PubMed ID: 20560786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of individual branched-chain amino acids deprivation on insulin sensitivity and glucose metabolism in mice.
    Xiao F; Yu J; Guo Y; Deng J; Li K; Du Y; Chen S; Zhu J; Sheng H; Guo F
    Metabolism; 2014 Jun; 63(6):841-50. PubMed ID: 24684822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression.
    Hwang HJ; Jung TW; Kim BH; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
    Biochem Pharmacol; 2015 Nov; 98(1):157-66. PubMed ID: 26297911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astaxanthin Inhibits p70 S6 Kinase 1 Activity to Sensitize Insulin Signaling.
    Li C; Ma B; Chen J; Jeong Y; Xu X
    Mar Drugs; 2020 Sep; 18(10):. PubMed ID: 32998286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinase.
    Rajan MR; Fagerholm S; Jönsson C; Kjølhede P; Turkina MV; Strålfors P
    PLoS One; 2013; 8(4):e59725. PubMed ID: 23565163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).
    Pearce LR; Alton GR; Richter DT; Kath JC; Lingardo L; Chapman J; Hwang C; Alessi DR
    Biochem J; 2010 Oct; 431(2):245-55. PubMed ID: 20704563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2.
    Zhang J; Gao Z; Yin J; Quon MJ; Ye J
    J Biol Chem; 2008 Dec; 283(51):35375-82. PubMed ID: 18952604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice.
    Yu Z; Shao W; Chiang Y; Foltz W; Zhang Z; Ling W; Fantus IG; Jin T
    Diabetologia; 2011 Apr; 54(4):922-34. PubMed ID: 21161163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver.
    Foretz M; Ancellin N; Andreelli F; Saintillan Y; Grondin P; Kahn A; Thorens B; Vaulont S; Viollet B
    Diabetes; 2005 May; 54(5):1331-9. PubMed ID: 15855317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α-Terpineol induces fatty liver in mice mediated by the AMP-activated kinase and sterol response element binding protein pathway.
    Choi YJ; Sim WC; Choi HK; Lee SH; Lee BH
    Food Chem Toxicol; 2013 May; 55():129-36. PubMed ID: 23274539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726 and its effect on cell proliferation and cell cycle progress.
    Doscas ME; Williamson AJ; Usha L; Bogachkov Y; Rao GS; Xiao F; Wang Y; Ruby C; Kaufman H; Zhou J; Williams JW; Li Y; Xu X
    Neoplasia; 2014 Oct; 16(10):824-34. PubMed ID: 25379019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum- and glucocorticoid-induced kinase drives hepatic insulin resistance by directly inhibiting AMP-activated protein kinase.
    Zhou B; Zhang Y; Li S; Wu L; Fejes-Toth G; Naray-Fejes-Toth A; Soukas AA
    Cell Rep; 2021 Oct; 37(1):109785. PubMed ID: 34610303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.